We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSHP
RNS Number : 5058M
Societe Generale SA
08 January 2019
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Full name of discloser: Société Générale S.A. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. ------------------------------------------- (c) Name of offeror/offeree in relation to whose relevant securities Shire Plc this form relates: Use a separate form for each offeror/offeree ------------------------------------------- (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: ------------------------------------------- (e) Date position held/dealing undertaken: 07/01/2019 For an opening position disclosure, state the latest practicable date prior to the disclosure ------------------------------------------- (f) In addition to the company in 1(c) above, is the discloser YES: Takeda Pharmaceutical Company Limited making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" ------------------------------------------- 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: Ordinary shares: 19,812,373 Shares Interests and 58,714 short position ADR (referencing the ordinary): 322,266 equivalent Shares interests and 41,643 equivalent Shares as short position Where (1 ADR = 3 ordinary shares) Interests Short positions ------------------------------------------- ------------------------------------------- Number % Number % --------------------------- --------------------------- -------------- (1) Relevant securities owned and/or controlled: 20,134,639 2.19 100,357 0.01 --------------------------- -------------- --------------------------- -------------- (2) Cash-settled derivatives: 0 0.00 19,399,108 2.11 --------------------------- -------------- --------------------------- -------------- (3) Stock-settled derivatives (including options) and agreements to purchase/sell: 593,100 0.06 473,700 0.05 --------------------------- -------------- --------------------------- -------------- TOTAL: 20,727,739 2.26 19,973,165 2.18 --------------------------- -------------- --------------------------- --------------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales Class of Purchase/sale Number of securities Price per relevant unit security GBP Ordinary Purchase - - ---------------- --------------------- ---------- Class of Purchase/sale Number of securities Price per relevant unit security USD ---------------- --------------------- ---------- ADR Purchase - - ---------------- --------------------- ---------- Class of Purchase/sale Number of securities Price per relevant unit security GBP ---------------- --------------------- ---------- Ordinary Sale - - ---------------- --------------------- ---------- Class of Purchase/sale Number of securities Price per relevant unit security USD ---------------- --------------------- ---------- ADR Sale - - ---------------- --------------------- ---------- Total Purchases - ---------------- --------------------- ---------- Total Sales - ---------------- --------------------- ---------- (b) Cash-settled derivative transactions Class of relevant Product description Nature of dealing Number of reference Price per unit GBP security e.g. CFD e.g. opening/closing a securities long/short position, increasing/reducing a long/short position closing a short Ordinary Listed call warrant position 40 18.95 --------------------- ----------------------- ----------------------- ------------------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry date Option money relevant description purchasing, securities price per e.g. paid/ security e.g. call selling, to which unit American, received per option varying etc. option European unit USD relates etc. (ii) Exercise Class of relevant Product description Exercising/ exercised Number of securities Exercise price per security e.g. call option against unit GBP (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing Details Price per unit (if applicable) GBP e.g. subscription, conversion 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none" (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? Yes Date of disclosure: 08/01/2019 Contact name: Olivier Vero ----------------- Telephone number: +44 20 7676 6969 -----------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION Full name of person making disclosure: SOCIETE GENERALE SA Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Shire Plc -------------------- 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
-
Class of Product Written Number Exercise price Type Expiry date relevant description or purchased of securities per unit USD security e.g. call to which option option or derivative relates e.g. American, European etc. ---------------- --------------- Listed American ADR call-option Purchase 75,000 170 option 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Sale 75,000 165 option 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Purchase 41,800 175 option 18/04/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Purchase 360,600 180 option 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Sale 226,900 175 option 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Purchase 41,800 200 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Sale 15,000 185 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Purchase 33,900 190 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR call-option Sale 20,000 172.5 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR put-option Sale 20,000 170 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR put-option Purchase 116,800 165 option 18/04/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR put-option Purchase 20,000 140 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ Listed American ADR put-option Sale 20,000 155 options 18/01/2019 ---------------- --------------- --------------- ---------------- --------------- ------------ 3. AGREEMENTS TO PURCHASE OR SELL ETC. Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RETEANFPESENEEF
(END) Dow Jones Newswires
January 08, 2019 04:51 ET (09:51 GMT)
1 Year Shire Chart |
1 Month Shire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions